Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Smoking Cessation 11Tobacco Use Disorder 7Smoking 5Lung Neoplasms 5Uterine Cervical Neoplasms 4Tobacco Use Cessation 4Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Tobacco Use 2Tobacco Smoking 2Small Cell Lung Carcinoma 2Head and Neck Neoplasms 2Cigarette Smoking 2Acquired Immunodeficiency Syndrome 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Substance-Related Disorders 1Stomach Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Overweight 1Oropharyngeal Neoplasms 1Neoplasms, Second Primary 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Laryngeal Neoplasms 1

Interventions

Cognitive Training 2Tobacco Use Cessation Devices 1Sodium Chloride 1Saline Solution 1Palliative Care 1Neuroprotective Agents 1Mesna 1Magnetic Resonance Spectroscopy 1High-Intensity Interval Training 1Functional Status 1Electroacupuncture 1Drug Therapy 1Doxorubicin 1Cyclophosphamide 1Ashwagandha 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-Related Cognitive Impairment × Tobacco Use Cessation Devices × Clear all
NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Vanderbilt University Medical Center

Phase 2 Completed
22 enrolled 14 charts
Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡